These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 32772402

  • 1. Antifungal drugs: An updated review of central nervous system pharmacokinetics.
    Wirth F, Ishida K.
    Mycoses; 2020 Oct; 63(10):1047-1059. PubMed ID: 32772402
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin CM.
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacology of antifungal agents in pediatrics: children are not small adults.
    Ramos-Martín V, O'Connor O, Hope W.
    Curr Opin Pharmacol; 2015 Oct; 24():128-34. PubMed ID: 26366938
    [Abstract] [Full Text] [Related]

  • 4. Antifungal pharmacodynamics: Latin America's perspective.
    Gonzalez JM, Rodriguez CA, Agudelo M, Zuluaga AF, Vesga O.
    Braz J Infect Dis; 2017 Oct; 21(1):79-87. PubMed ID: 27821250
    [Abstract] [Full Text] [Related]

  • 5. CNS-aspergillosis: are there new treatment options?
    Schwartz S, Thiel E.
    Mycoses; 2003 Oct; 46 Suppl 2():8-14. PubMed ID: 15055138
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of antifungal agents in children.
    Watt K, Benjamin DK, Cohen-Wolkowiez M.
    Early Hum Dev; 2011 Mar; 87 Suppl 1(Suppl 1):S61-5. PubMed ID: 21277714
    [Abstract] [Full Text] [Related]

  • 7. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P.
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [Abstract] [Full Text] [Related]

  • 8. Antifungal agents in neonates: issues and recommendations.
    Almirante B, Rodríguez D.
    Paediatr Drugs; 2007 Mar; 9(5):311-21. PubMed ID: 17927303
    [Abstract] [Full Text] [Related]

  • 9. New facets of antifungal therapy.
    Chang YL, Yu SJ, Heitman J, Wellington M, Chen YL.
    Virulence; 2017 Feb 17; 8(2):222-236. PubMed ID: 27820668
    [Abstract] [Full Text] [Related]

  • 10. Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.
    Schwartz S, Cornely OA, Hamed K, Marty FM, Maertens J, Rahav G, Herbrecht R, Heinz WJ.
    Med Mycol; 2020 Jun 01; 58(4):417-424. PubMed ID: 31613363
    [Abstract] [Full Text] [Related]

  • 11. Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies.
    Zeng H, Wu Z, Yu B, Wang B, Wu C, Wu J, Lai J, Gao X, Chen J.
    BMC Cancer; 2021 Apr 14; 21(1):404. PubMed ID: 33853560
    [Abstract] [Full Text] [Related]

  • 12. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Perkhofer S, Lass-Flörl C.
    Expert Opin Investig Drugs; 2009 Sep 14; 18(9):1393-404. PubMed ID: 19656074
    [Abstract] [Full Text] [Related]

  • 13. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M.
    J Crit Care; 2011 Apr 14; 26(2):225.e1-10. PubMed ID: 20951541
    [Abstract] [Full Text] [Related]

  • 14. Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
    Gómez-López A.
    Clin Microbiol Infect; 2020 Nov 14; 26(11):1481-1487. PubMed ID: 32535150
    [Abstract] [Full Text] [Related]

  • 15. Clinical hepatotoxicity associated with antifungal agents.
    Kyriakidis I, Tragiannidis A, Munchen S, Groll AH.
    Expert Opin Drug Saf; 2017 Feb 14; 16(2):149-165. PubMed ID: 27927037
    [Abstract] [Full Text] [Related]

  • 16. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M, Flowers SA, Rogers PD.
    Ann Pharmacother; 2009 Oct 14; 43(10):1696-700. PubMed ID: 19724015
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE.
    Curr Opin Pharmacol; 2007 Oct 14; 7(5):491-7. PubMed ID: 17616480
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of antifungal agents in neonates and young infants.
    Regazzi M, Billaud EM, Lefeuvre S, Stronati M.
    Curr Med Chem; 2012 Oct 14; 19(27):4621-32. PubMed ID: 22876899
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Jullien V.
    Arch Pediatr; 2011 May 14; 18 Suppl 1():S42-7. PubMed ID: 21596286
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system.
    Stott KE, Hope W.
    Expert Opin Drug Metab Toxicol; 2018 Aug 14; 14(8):803-815. PubMed ID: 29943650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.